Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

SNM1A is crucial for efficient repair of complex DNA breaks in human cells

LP. Swift, BC. Lagerholm, LR. Henderson, M. Ratnaweera, HT. Baddock, B. Sengerova, S. Lee, A. Cruz-Migoni, D. Waithe, C. Renz, HD. Ulrich, JA. Newman, CJ. Schofield, PJ. McHugh

. 2024 ; 15 (1) : 5392. [pub] 20240625

Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24013446

Grant support
Wellcome Trust - United Kingdom
CRUK/ A24759 Cancer Research UK (CRUK)

DNA double-strand breaks (DSBs), such as those produced by radiation and radiomimetics, are amongst the most toxic forms of cellular damage, in part because they involve extensive oxidative modifications at the break termini. Prior to completion of DSB repair, the chemically modified termini must be removed. Various DNA processing enzymes have been implicated in the processing of these dirty ends, but molecular knowledge of this process is limited. Here, we demonstrate a role for the metallo-β-lactamase fold 5'-3' exonuclease SNM1A in this vital process. Cells disrupted for SNM1A manifest increased sensitivity to radiation and radiomimetic agents and show defects in DSB damage repair. SNM1A is recruited and is retained at the sites of DSB damage via the concerted action of its three highly conserved PBZ, PIP box and UBZ interaction domains, which mediate interactions with poly-ADP-ribose chains, PCNA and the ubiquitinated form of PCNA, respectively. SNM1A can resect DNA containing oxidative lesions induced by radiation damage at break termini. The combined results reveal a crucial role for SNM1A to digest chemically modified DNA during the repair of DSBs and imply that the catalytic domain of SNM1A is an attractive target for potentiation of radiotherapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013446
003      
CZ-PrNML
005      
20240905134236.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41467-024-49583-5 $2 doi
035    __
$a (PubMed)38918391
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Swift, Lonnie P $u Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom $1 https://orcid.org/0000000250262485
245    10
$a SNM1A is crucial for efficient repair of complex DNA breaks in human cells / $c LP. Swift, BC. Lagerholm, LR. Henderson, M. Ratnaweera, HT. Baddock, B. Sengerova, S. Lee, A. Cruz-Migoni, D. Waithe, C. Renz, HD. Ulrich, JA. Newman, CJ. Schofield, PJ. McHugh
520    9_
$a DNA double-strand breaks (DSBs), such as those produced by radiation and radiomimetics, are amongst the most toxic forms of cellular damage, in part because they involve extensive oxidative modifications at the break termini. Prior to completion of DSB repair, the chemically modified termini must be removed. Various DNA processing enzymes have been implicated in the processing of these dirty ends, but molecular knowledge of this process is limited. Here, we demonstrate a role for the metallo-β-lactamase fold 5'-3' exonuclease SNM1A in this vital process. Cells disrupted for SNM1A manifest increased sensitivity to radiation and radiomimetic agents and show defects in DSB damage repair. SNM1A is recruited and is retained at the sites of DSB damage via the concerted action of its three highly conserved PBZ, PIP box and UBZ interaction domains, which mediate interactions with poly-ADP-ribose chains, PCNA and the ubiquitinated form of PCNA, respectively. SNM1A can resect DNA containing oxidative lesions induced by radiation damage at break termini. The combined results reveal a crucial role for SNM1A to digest chemically modified DNA during the repair of DSBs and imply that the catalytic domain of SNM1A is an attractive target for potentiation of radiotherapy.
650    _2
$a lidé $7 D006801
650    12
$a dvouřetězcové zlomy DNA $x účinky záření $7 D053903
650    12
$a exodeoxyribonukleasy $x metabolismus $x genetika $7 D005090
650    12
$a oprava DNA $7 D004260
650    12
$a enzymy opravy DNA $x metabolismus $x genetika $7 D045643
650    _2
$a proliferační antigen buněčného jádra $x metabolismus $x genetika $7 D018809
650    _2
$a DNA $x metabolismus $x genetika $7 D004247
650    _2
$a ubikvitinace $7 D054875
650    _2
$a proteiny buněčného cyklu $7 D018797
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lagerholm, B Christoffer $u Wolfson Imaging Centre, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom $u Cell Imaging and Cytometry Core, Turku Bioscience Centre, University of Turku and Åbo Akademi, ku, Finland
700    1_
$a Henderson, Lucy R $u Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom $1 https://orcid.org/0000000201425444
700    1_
$a Ratnaweera, Malitha $u Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom $1 https://orcid.org/0000000300173801
700    1_
$a Baddock, Hannah T $u Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom $u Calico Life Sciences, South San Francisco, CA, USA
700    1_
$a Sengerova, Blanka $u Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000280825947
700    1_
$a Lee, Sook $u Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
700    1_
$a Cruz-Migoni, Abimael $u Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom $1 https://orcid.org/0000000159374101
700    1_
$a Waithe, Dominic $u Wolfson Imaging Centre, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
700    1_
$a Renz, Christian $u Institute of Molecular Biology gGmbH (IMB), Mainz, Germany $1 https://orcid.org/0000000331643597
700    1_
$a Ulrich, Helle D $u Institute of Molecular Biology gGmbH (IMB), Mainz, Germany $1 https://orcid.org/0000000304312223
700    1_
$a Newman, Joseph A $u Centre for Medicines Discovery, University of Oxford, Oxford, United Kingdom $1 https://orcid.org/0000000344880516
700    1_
$a Schofield, Christopher J $u Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, United Kingdom $1 https://orcid.org/0000000202906565
700    1_
$a McHugh, Peter J $u Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom. peter.mchugh@imm.ox.ac.uk $1 https://orcid.org/0000000286794627
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 15, č. 1 (2024), s. 5392
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38918391 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134230 $b ABA008
999    __
$a ok $b bmc $g 2143334 $s 1225312
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c 1 $d 5392 $e 20240625 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
GRA    __
$p Wellcome Trust $2 United Kingdom
GRA    __
$a CRUK/ A24759 $p Cancer Research UK (CRUK)
LZP    __
$a Pubmed-20240725
Back

Find record

Citation metrics

Archiving options